Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 10 , ISSUE 4 ( October-December, 2018 ) > List of Articles


Cell-free Fetal Deoxyribonucleic Acid Results in Low-risk Pregnancy Screenings for Aneuploidies

Nahid Shahbazian, Mojgan Barati, Kobra Shojaei, S Saheb Hoseininejad, Azadeh M Dehghani

Keywords : Aneuploidy risk, Aneuploidy screen, Cell-free DNA, Low-risk pregnancy

Citation Information : Shahbazian N, Barati M, Shojaei K, Hoseininejad SS, Dehghani AM. Cell-free Fetal Deoxyribonucleic Acid Results in Low-risk Pregnancy Screenings for Aneuploidies. J South Asian Feder Obs Gynae 2018; 10 (4):249-252.

DOI: 10.5005/jp-journals-10006-1600

License: CC BY-NC 4.0

Published Online: 01-10-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Introduction: Chromosomal aneuploidies are a common type of chromosomal defect that may impose heavy burdens on society and families. The most common chromosomal aneuploidies among the embryos are trisomies 21, 18, and 13. Prenatal screening and diagnosis are often used in prenatal care, and it seems to be a handy tool for doctors and women to make informed decisions about the continuation of pregnancies involved with genetic diseases. Prenatal noninvasive tests using cell-free fetal deoxyribonucleic acid (cff DNA) are a method for testing trisomy in embryos using the peripheral blood sample of the pregnant mother. Because most of the studies carried out on cff DNA have been in high-risk populations, this study attempted to examine the results of cff DNA in a population of low-risk aneuploidy pregnant women. Materials and methods: In this retrospective study, the study population was all pregnant women (n = 410), who underwent aneuploidy screening during the first or second trimester (with a low-risk result in quad test) in 2015–2016 and were at the risk of trisomies 13, 18, and 21 evaluated using cell-free fetal DNA test. Results: The mean age of pregnant women was 31.5 years, and 92.0% of the subjects were naturally pregnant, and only 8.1% had used assisted reproductive techniques (ART). Of these, 5.9% were fertilized by In vitro fertilization (IVF) and 2.2% by IUI method. Results of cff DNA in all pregnant women were negative. Conclusion: According to the results of this study, cff DNA testing results in all low-risk pregnant women were negative, and it is not recommended as a routine test in pregnant women reported as a low-risk pregnancy in serum screening.

PDF Share
  1. Driscoll DA, Gross S. Prenatal screening for aneuploidy. New England Journal of Medicine. 2009;360(24):2556-2562.
  2. Verweij E, Van Den Oever J, De Boer M, Boon E, Oepkes D. Diagnostic accuracy of noninvasive detection of fetal trisomy 21 in maternal blood: a systematic review. Fetal diagnosis and therapy. 2012;31(2):81-86.
  3. Stein W, Müller S, Gutensohn K, Emons G, Legler T. Cell-free fetal DNA and adverse outcome in low risk pregnancies. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2013;166(1):10-13.
  4. Gil MdM, Quezada MS, Bregant B, Syngelaki A, Nicolaides KH. Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal diagnosis and therapy. 2014;35(3):204-211.
  5. Costa CA. Noninvasive prenatal screening for chromosomal abnormalities using circulating cell-free fetal DNA in maternal plasma: Current applications, limitations and prospects. Egyptian Journal of Medical Human Genetics. 2017;18(1):1-7.
  6. Taylor-Phillips S, Freeman K, Geppert J, Agbebiyi A, Uthman OA, Madan J, et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ open. 2016;6(1):e010002.
  7. Radoi VE, Bohiltea CL, Bohiltea RE, Albu DN. Cell free fetal DNA testing in maternal blood of Romanian pregnant women. Iranian journal of reproductive medicine. 2015;13(10):623.
  8. Hudecova I, Sahota D, Heung MM, Jin Y, Lee WS, Leung TY, et al. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PloS one. 2014;9(2):e88484.
  9. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, et al. Cell-free DNA analysis for noninvasive examination of trisomy. New England Journal of Medicine. 2015;372(17):1589-1597.
  10. Norton ME, Baer RJ, Wapner RJ, Kuppermann M, Jelliffe- Pawlowski LL, Currier RJ. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities. American Journal of Obstetrics & Gynecology. 2016;214(6):727. e1-e6.
  11. Persico N, Boito S, Ischia B, Cordisco A, De Robertis V, Fabietti I, et al. Cell-free DNA testing in the maternal blood in high-risk pregnancies after first-trimester combined screening. Prenatal diagnosis. 2016;36(3):232-236.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.